4559 Stock Overview
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4559 from our risk checks.
Zeria Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,075.00 |
| 52 Week High | JP¥2,471.00 |
| 52 Week Low | JP¥1,880.00 |
| Beta | 0.037 |
| 11 Month Change | 1.82% |
| 3 Month Change | 0.29% |
| 1 Year Change | -11.81% |
| 33 Year Change | 1.12% |
| 5 Year Change | -1.05% |
| Change since IPO | 90.21% |
Recent News & Updates
Zeria Pharmaceutical's (TSE:4559) Earnings Are Of Questionable Quality
May 21
Zeria Pharmaceutical (TSE:4559) Has Announced A Dividend Of ¥22.00
Mar 15Shareholder Returns
| 4559 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.8% | 3.6% | 2.4% |
| 1Y | -11.8% | 16.4% | 24.6% |
Return vs Industry: 4559 underperformed the JP Pharmaceuticals industry which returned 16.4% over the past year.
Return vs Market: 4559 underperformed the JP Market which returned 24.6% over the past year.
Price Volatility
| 4559 volatility | |
|---|---|
| 4559 Average Weekly Movement | 2.7% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4559 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4559's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 1,777 | Sachiaki Ibe | www.zeria.co.jp |
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn’s disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; and proton pump inhibitors.
Zeria Pharmaceutical Co., Ltd. Fundamentals Summary
| 4559 fundamental statistics | |
|---|---|
| Market cap | JP¥91.47b |
| Earnings (TTM) | JP¥7.73b |
| Revenue (TTM) | JP¥75.73b |
11.8x
P/E Ratio1.2x
P/S RatioIs 4559 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4559 income statement (TTM) | |
|---|---|
| Revenue | JP¥75.73b |
| Cost of Revenue | JP¥20.22b |
| Gross Profit | JP¥55.50b |
| Other Expenses | JP¥47.77b |
| Earnings | JP¥7.73b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 175.39 |
| Gross Margin | 73.29% |
| Net Profit Margin | 10.21% |
| Debt/Equity Ratio | 57.9% |
How did 4559 perform over the long term?
See historical performance and comparison